We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Percutaneous renal denervation in the management of hypertension: Chinese expert scientific statement
PeriodicalsMedical Sciences

Percutaneous renal denervation in the management of hypertension: Chinese expert scientific statement

Checking your access to this record.

Abstract & Overview

Hypertension constitutes a critical risk factor for cardio-cerebrovascular disease. Despite the effectiveness of lifestyle adjustments and medications in blood pressure (BP) management, the hypertension control rates remain inadequate. Percutaneous renal denervation (RDN) has emerged as a forward-looking and evidence-supported interventional modality for the improvement of BP regulation and enhancement of hypertension control. Comprehensive evidence from randomized, sham-controlled clinical trials supports the sustained the efficacy and satisfactory safety profile of RDN in lowing BP. This scientific statement, endorsed by Chinese authorities, aims to provide a comprehensive overview of global and national clinical evidence on RDN. It seeks to highlight the therapeutic advancements of RDN, articulate expert consensus and recommendations for its utilization in hypertension management. Through the promotion of structured, safe, and standardized incorporation of RDN into clinical practice, this statement strives to optimize hypertension treatment within the Chinese medical community.

Cite this record

Yueping Li, Chengzhi Lu, Xiongjing Jiang, Jing Yu, Ma Wei, Jialu Hu, et al. (2024). Percutaneous renal denervation in the management of hypertension: Chinese expert scientific statement. Cardiology Plus, 9(2), 133–149. https://doi.org/10.1097/cp9.0000000000000083

Copy in another style

Li, Y., Lu, C., Jiang, X., Yu, J., Wei, M., Hu, J., Zhang, Y. S., Zhou, Y., Sun, N., & Huo, Y. (2024). Percutaneous renal denervation in the management of hypertension: Chinese expert scientific statement. Cardiology Plus, 9(2), 133–149. https://doi.org/10.1097/cp9.0000000000000083
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.